PSYCHIATRIC PHARMACOLOGY
I. Psychosis is a severe psychiatric disturbance characterized by
A. Impaired behavior
B. Inability to think coherently
C. Inability to comprehend reality
D. Inability to understand disturbance
E. Symptoms may include delusions and hallucinations
II. Examples
. Schizophrenia (disordered thinking, emotional withdrawal, paranoid delusions and auditory hallucinations)
A. Organic psychoses (e.g., delirium and dementia)
B. Agitated psychotic depressions
C. Mania (?)
III. Antipsychotic agents
. Also called major tanquilizers or neuroleptics
A. Response to antipsychotic drug therapy
IV. Major side effects of antipsychotics (Extrapyramidal motor effects)
. Early onset symptoms (days to weeks)
A. Late onset symptoms (months to years)
V. Proposed mechanism of action
. Antipsychotic effects - antagonism (receptor blockade) of (excessive?) dopaminergic function (DA2 receptors) in the limbic system and other areas of the brain
Psychosis Parkinsonism |
A. Extrapyramidal - Antagonism of (normal) dopaminergic function in the basal ganglia (striatum) an area of the brain involved in posture and fine aspects of movement)
a. Thioridazine - high AntiACh - low extrapyramidal
b. Fluphenazine - low AntiACh - high extrapyramidal
The caudate nucleus receives cholinergic excitatory (+) innervation from the cortex and other areas of the brain and dopaminergic inhibitory (-) innervation from the substantia nigra. The output from the caudate regulates fine skeletal motor activity and depends upon a precise balance of cholinergic and dopaminergic activity. |
B. Tardive dyskinesia - "disuse supersensitivity" - prolonged absence of neurotransmitter causes receptor to become extremely sensitive to released dopamine, such that when drug is discontinued and the receptor is no longer blocked, it is bombarded normally released transmitter.
VI. Miscellaneous uses
. Nausea and vomiting
A. Intractable hiccough
B. other neuropsychiatric disorders
C. Amphetamine "psychosis"
D. Phencyclidine and ketamine overdose
VII. Drug interactions
. potentiation of opiates, barbiturates and ethanol
A. lower doses of barbs needed in anesthesia
B. lowered seizure threshold - use with care in epileptics
VIII. Side effects
. extrapyramidal
A. orthostatic hypotension
B. nasal stuffiness
C. dry mouth
D. palpitations
E. constipation
F. sedation
G. suppression of bone marrow function and agranulocytosis
H. Neuroleptic Malignant syndrome (NMS)
IX. Tolerance and dependence
. tolerance develops to sedative (days) and hypotensive (weeks) effects but not to antipsychotic effects
A. some reports of muscular discomfort, insomnia, nausea, headache, restlessness upon abrupt discontinuation
X. Toxicity - high therapeutic indices (relatively safe- in terms of lethality, see table below)
XI. Comparison of antipsychotic drugs
. chemical classification - phenothiazines, butyrophenones, thioxanthines
A.
See table below
|
|||||
|
|
||||
Drugs |
TI |
Antipsychotic Activity |
Sedation |
Extrapyramidal |
Hypotension |
Chlorpromazine |
200 |
+ |
+++ |
++ |
++ |
Haloperidol |
>1000 |
+++ |
+ |
+++ |
+ |
Thioridazine |
70 |
+ |
+++ |
+ |
++ |
Fluphenazine |
|
+++ |
+ |
+++ |
+ |
Trifluoperazine |
|
+++ |
+ |
+++ |
+ |
Clozapine |
|
+ |
+++ |
- |
+++ |
XII. Drugs of choice
. compliance - long acting drug - fluphenazine
A. CV disease - little hypotensive effect - fluphenazine, trifluperazine, haloperidol, amolindone
B. older patients or patients with predisposition to extrapyramidal side effects - thioridazine, amolindone
C. if no sedation wanted - fluphenazine, trifluperazine, haloperidol
D. if patient is taking quinidine for arrhythmias, don't use thioridazine (direct myocardial depressant)